［1］刘文娴，吕树铮，陈立颖，等.高龄急性冠脉综合征患者血运重建问题初探［J］.中华急诊医学杂志，2004，13 （8）:545-547. ［2］ Overbaugh KJ.Acute coronary syndrome［J］.Am J Nurs， 2009，109（5）:42-52. ［3］汤日波，刘晓辉，谢莲娜，等.APACHEⅡ评分在急性冠脉综合征中的应用［J］.中华急诊医学杂志，2005，14 （8）:682-683. ［4］ From AM，Rihal CS，Lennon RJ， et al.Temporal trends and improved outcomes of percutaneous coronary revascu- larization in nonagenarians［J］.JACC Cardiovasc Interv， 2008，1（6）:692-698.［5］ Chaowalit N，Yipintsoi T，Tresukosol D，et al.Prognostic value of selected presenting features of acute coronary syndrome in predicting inhospital adverse events:insight from the Thai acute coronary syndrome registry［J］.Intern Med， 2009，48（9）:639-646. ［6］陆再英，钟南山.内科学［M］.7版.北京:人民卫生出版社，2008:268. ［7］ Effects of platelet glycoproteinⅡb/Ⅲa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The restore investigators. Randomized efficacy study of tirofiban for outcomes and restenosis［J］. Circulation， 1997， 96（5）:1445-1453. ［8］张燕，刘鹏，李靖.替罗非班对冠心病PCI术中内皮功能障碍的影响［J］.中国误诊学杂志， 2006， 6（16）: 3069-3071.
2012, Vol. 21 
